Officer received an award of 12K MET shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 30, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- May 4, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0002083481-26-000006
- Filed / recorded
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly Reporting personAdrienne Karen O'neill Officer titleEVP & Chief Accounting Officer TableNon-derivative (Table I) Transaction dateApr 30, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
MetLife's & Chief Risk Officer sold $1.74M of MetLife shares. Nobody planned it ahead of time.